Position in RXRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$564,683
+$561,039 QoQ
Shares Held
183,936
+20543.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Havemeyer Place LP holds $25,637,090 across 20 Biotechnology names. RXRX ranks #17 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
91,195 | $4,632,706 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,655 | $2,525,183 | |
| 3 | ARGX |
Argenx SE
|
3,431 | $2,505,487 | |
| 4 | INSM |
INSMED Inc
|
12,461 | $2,037,622 | |
| 5 | INCY |
Incyte Corp
|
19,145 | $1,801,927 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
109,439 | $1,403,007 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
4,471 | $1,327,752 | |
| 8 | SMMT |
Summit Therapeutics Inc.
|
61,989 | $1,175,311 |
All Filings in RXRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $564,683 | 183,936 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,644 | 891 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||